1 interaction related to niacinamide
The carbamazepine label lists niacinamide (nicotinamide) among substances shown or expected to raise carbamazepine levels by slowing CYP3A4, the liver enzyme that clears it, and says levels should be closely monitored with doses adjusted when such drugs are combined. The human evidence is a 1982 report in which nicotinamide, given on purpose in the study, raised carbamazepine levels in two patients; the report's summary does not state the doses or the size of the rise. No study has tested the smaller amounts in most multivitamins and B-complex products.